Related Experiment Video
Updated: Jun 25, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
Ectopic cervical thymoma in myasthenia gravis: a case report
Shima Zargar1, Maryam Hosseini Farahabadi2, Samuel J Reynolds3
1Department of Neurology, The University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA.
BMC Neurology
|May 23, 2024
Summary
Ectopic cervical thymoma (ECT) is rare, especially with myasthenia gravis (MG). Surgical removal of a cervical thymoma significantly improved MG symptoms and reduced medication needs.
Area of Science:
- Oncology
- Neurology
- Endocrinology
Background:
- Ectopic cervical thymoma (ECT) is an exceptionally rare condition.
- Its association with myasthenia gravis (MG) is particularly uncommon.
Observation:
- A case of generalized myasthenia gravis (MG) presented with worsening symptoms.
- A cervical mass, initially misdiagnosed, was identified as a type A thymoma.
- The patient had acetylcholine receptor-antibody (AChR-Ab) positivity.
Findings:
- Complete surgical removal of the ectopic cervical thymoma led to significant improvement in myasthenic symptoms.
- Post-operative radiation therapy was administered.
- The patient experienced reduced requirements for prednisone and pyridostigmine, with no need for further immunotherapy.
Implications:
- Diagnosing ectopic thymomas is challenging due to their rarity and potential misinterpretation of fine needle aspiration cytology (FNAC) results.
- Early detection and surgical intervention (thymectomy) for ectopic thymomas in MG patients can lead to favorable clinical outcomes.
- Vigilance for atypical thymoma locations is crucial for timely diagnosis and effective management, potentially reducing immunosuppressive medication dependency.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
782
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
782
Disorders of the Skeletal Muscle
931
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
931
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Muscle Contraction
6.3K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
6.3K

